BridgeBio Pharma
BBIO
$24.33
Share price
-2.80%
Change (1 day)
65.96%
Change (1 year)
Categories
Market capitalization of BridgeBio Pharma (BBIO)
Market cap: $4.48 Billion
As of April 2024 BridgeBio Pharma has a market cap of $4.48 Billion. This makes BridgeBio Pharma the world's 2782th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BridgeBio Pharma from 2019 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $4.48 B | -36.1% |
| 2023 | $7.02 B | 516.56% |
| 2022 | $1.13 B | -53.61% |
| 2021 | $2.45 B | -71.86% |
| 2020 | $8.72 B | 101.31% |
| 2019 | $4.33 B |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of BridgeBio Pharma was reported to be:
$4.48 Billion
$4.48 Billion
$4.27 Billion
$4.28 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.85 B | -81.05% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.9 M | -99.53% | 🇺🇸 USA |